Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
27.8M
-
Number of holders
-
133
-
Total 13F shares, excl. options
-
13.1M
-
Shares change
-
-283K
-
Total reported value, excl. options
-
$349M
-
Value change
-
+$1.17M
-
Put/Call ratio
-
0.4
-
Number of buys
-
76
-
Number of sells
-
-53
-
Price
-
$26.61
Significant Holders of ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) as of Q3 2016
152 filings reported holding ENTA - ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share as of Q3 2016.
ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) has 133 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.1M shares
of 27.8M outstanding shares and own 47.24% of the company stock.
Largest 10 shareholders include BlackRock Fund Advisors (1.29M shares), Krensavage Asset Management, LLC (1M shares), GREAT POINT PARTNERS LLC (790K shares), RENAISSANCE TECHNOLOGIES LLC (701K shares), VANGUARD GROUP INC (697K shares), SENZAR ASSET MANAGEMENT, LLC (507K shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (471K shares), FMR LLC (412K shares), AJO, LP (406K shares), and BlackRock Institutional Trust Company, N.A. (391K shares).
This table shows the top 133 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.